Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trial

Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trial

<p>Abstract</p> <p>Background</p> <p>Sudden sensorineural hearing loss (SSHL) is a common condition in which patients lose the hearing in one ear within 3 days. Systemic glucocorticoid treatments have been used as standard therapy for SSHL; however, about 20% of patient...

Full description

Bibliographic Details
Main Authors: Teramukai Satoshi, Tabata Yasuhiko, Yamamoto Masaya, Ono Kazuya, Hamaguchi Kiyomi, Yamamoto Norio, Kikkawa Yayoi S, Hiraumi Harukazu, Sakamoto Tatsunori, Nakagawa Takayuki, Tanaka Shiro, Tada Harue, Onodera Rie, Yonezawa Atsushi, Inui Ken-ichi, Ito Juichi
Format: Article
Language:English
Published: BMC 2010-11-01
Series:BMC Medicine
Online Access:http://www.biomedcentral.com/1741-7015/8/76

Internet

http://www.biomedcentral.com/1741-7015/8/76

Similar Items